Nicolay et al. demonstrated that DMF downregulated NF-κB in cutaneous T-cell lymphoma cells, restored the apoptosis sensitivity, and inhibited tumor growth [37]. The gene discussed is NFKB1; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.